Table 2.
Boron concentration in ppm (mean ± SD) for each tissue and tumor/blood, tumor/precancerous, and tumor/normal tissue boron concentration ratios (calculated as in [44]) for MID:BSA 15 mg B/kg at 12 h and 19 h post-injection. One to two samples were measured per tissue. Each animal bears 2 to 8 tumors, approximately. Exceptionally, in the case of the 19 h protocol, one of the animals did not exhibit tumors.
| MID:BSA 15 mg B/kg 12 h-Protocol | MID:BSA 15 mg B/kg 19 h-Protocol | |||
|---|---|---|---|---|
| Tissue | n | ppm ± SD | n | ppm ± SD |
| Tumor | 15 tumors | 32.4 ± 9.0 | 27 tumors | 31.7 ± 11.1 |
| Precancerous tissue | 4 animals | 15.7 ± 3.0 | 8 animals | 24.3 ± 11.3 |
| Normal | 4 animals | 5.5 ± 1.3 | 8 animals | 6.8 ± 1.5 |
| Liver | 4 animals | 27.4 ± 5.3 | 8 animals | 30.4 ± 12.7 |
| Kidney | 4 animals | 25.2 ± 3.9 | 8 animals | 27.5 ± 7.6 |
| Spleen | 4 animals | 14.0 ± 3.7 | 4 animals | 17.7 ± 3.8 |
| Blood | 4 animals | 41.9 ± 6.8 | 8 animals | 23.2 ± 9.0 |
| Tumor/precancerous tissue | 2.1 ± 0.6 | 1.3 ± 0.6 | ||
| Tumor/normal tissue | 6.1 ± 0.9 | 4.7 ± 1.4 | ||
| Tumor/blood | 0.8 ± 0.1 | 1.6 ± 1.1 | ||